Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Controlled Trial for Prevention of Loss of the Effect of Epilepsy Drugs

NCT03747705 is registered in ClinicalTrials.gov with Tahel Ilan Ber as lead sponsor.

NCT NCT03747705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03747705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Controlled Trial for Prevention of Loss of the Effect of Epilepsy Drugs
Lead sponsor
Tahel Ilan Ber
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2019
Completion date
November 12, 2019
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy